Delivery Order SPE2DB24D3014-SPE2DB25FKRYY
Award Date
11/8/24
Potential Completion Date
11/12/24
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical supplies. The $12,558.00 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 6, 2025, with a completion date of March 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award from the Defense Logistics Agency (DLA) is for the procurement of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product, by the U.S. government. The $7,089.60 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 19, 2025 and was not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999...
This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical supplies to the Defense Logistics Agency (DLA). The contract, valued at $17,837.40, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 12, 2024. The contract is a delivery order with a firm fixed price, and the ultimate completion date is August 13, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office division is...
This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product, to the Defense Logistics Agency (DLA). The $7,089.60 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 21, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
The federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S to the Defense Logistics Agency (DLA). The $2,081.46 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor that provides medical products to federal government agencies, particularly military and veterans' healthcare programs. The contract has an ultimate completion date of March 27, 2025 and is not designated as a set-aside. Amerisourcebergen holds a...
The federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S to the Defense Logistics Agency (DLA). The award, valued at $6,502.20, was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price, and the ultimate completion date is January 10, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
The federal contract award is for the delivery of EPINEPHRINE 0.15 MG AUTO-INJCT 2S, a critical pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,209.03 fixed-price contract was awarded to AmerisourceBergen Drug Corporation, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has an ultimate completion date of July 31, 2024 and is not set aside. As a significant Indefinite Delivery Contract (IDC) holder with the DLA...
This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,952.76 delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distribution company, on August 26, 2024, with a completion date of August 27, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECTOR 2S, a critical medical product. The $3,020.50 Firm Fixed Price contract has a completion date of January 22, 2024. AmerisourceBergen, a major pharmaceutical distributor, is delivering this product through a DLA Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical products, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award, valued at $8,069.52, is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 30, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, is a for-profit organization registered in the System for Award Management...